Bafna Pharmaceuticals Ltd Quarterly Results
Q2 FY19-20 Results Summary
Revenue
The revenue stands at ₹11.57 crore, reflecting a quarter-on-quarter *(QoQ) increase of 68.91 per cent from ₹6.85 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Operating Profit
Operating Profit stands at ₹-0.37 crore, reflecting a quarter-on-quarter *(QoQ) increase of 87.11 per cent from ₹-2.87 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
PBDT
PBDT stands at ₹0.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 106.32 per cent from ₹-2.69 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-0.55 crore, reflecting a quarter-on-quarter *(QoQ) increase of 85.18 per cent from ₹-3.71 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Net Profit
Net Profit stands at ₹-0.59 crore, reflecting a quarter-on-quarter *(QoQ) increase of 72.30 per cent from ₹-2.13 crore. This represents a 0.00 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Bafna Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Bafna Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Bafna Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Bafna Pharmaceuticals Ltd Financial Reports
Bafna Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Bafna Pharma. | 5.00% | 15.74% | 48.13% | 75.66% | 27.24% | 141.98% |
| Kilitch Drugs | -3.97% | -3.08% | 1.49% | 44.14% | 7.36% | -15.98% |
| Amanta Healthcar | -0.68% | 0.59% | 29.82% | 62.40% | 52.31% | 15.00% |
| Jenburkt Pharma | -0.35% | 0.41% | -2.02% | 18.06% | 4.10% | -17.79% |
| Haleos Labs Limited | -5.34% | 1.08% | -17.16% | 16.73% | 10.33% | 14.82% |
| Aptus Pharma | 0.73% | 4.63% | 26.90% | 68.37% | 249.93% | 592.84% |
| Albert David | -2.23% | -1.68% | -0.87% | 18.93% | -5.53% | -16.47% |
Company Info
Company Information
E D & Wholetime Director : Shanmugam Hemalatha
ED / WTD : Vinayak Dinesh Dendukuri
Non-Exec & Non-Independent Dir : Upendar Mekala Reddy
Chairman & Independent Directo : Ravichandran Chitra
Company Sec. & Compli. Officer : A Mohanachandran
Non Executive Director : Akilapriya Chandrashekar Raju
Independent Non Exe. Director : Palamadai Krishnan Sundaresan